The economic case made for global [Covid-19] vaccinations

COVID-19 Dark Backgroundsource: The ICC
published: 2021

A study commissioned by the International Chamber of Commerce (ICC) Research Foundation has found that the global economy stands to lose as much as US$9.2 trillion if governments fail to ensure developing economy access to COVID-19 vaccines.

The COVID-19 pandemic had a devastating effect on both lives and livelihoods in 2020. The arrival of effective vaccines can be a major game changer in mitigating the economic, social and health consequences of the virus in the year ahead.

However, evidence to date suggests that access to these vaccines is likely to be highly uneven across countries. Advanced economies have in recent months pursued a policy of securing the global supply of frontrunner vaccines – as a result severely limiting their availability in emerging markets.

Moreover, the Access to COVID-19 Tools (ACT) Accelerator – the proven global platform to enable equitable access to COVID-19 test, treatments and vaccines – remains underfunded by the world’s largest economies, constraining its ability to procure vaccines at scale for the developing world.

A new study highlights the major risks to the global economy inherent in this uncoordinated approach to vaccine access.

Read full article & download study >

Related News:

Tracking Coronavirus vaccinations around the world
16 December 2021

Coronavirus (COVID-19) Vaccinations (statistics & research)
17 December 2021

Sponsored Advertisement